Last edition
News about "Nasal Spray Influenza Vaccine "
FDA Approves Nasal Spray Influenza Vaccine for Caregiver Administration
FluMist is approved for preventing influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age.
Nasal Spray Influenza Vaccine | 21/09/2024 | By Aishwarya | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members